Skip to main content
Fig. 4 | BMC Genomics

Fig. 4

From: Identification and validation of a prognostic model for melanoma patients with 9 ferroptosis-related gene signature

Fig. 4

The prognostic model validation in the validation cohort. A The risk score distribution of in the validation cohort. B the validation cohort PCA analysis. C the validation cohort T-SNE plot. D The OS distribution in the validation cohort. E The Kaplan–Meier survival OS analysis between the high-risk group and low-risk group in the validation cohort. F The risk signature AUC in ROC analysis for 1-, 2- and 3-year survival time in the validation cohort

Back to article page